|
CYP51A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.239980E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.834020E-01 |
| Normal-vs-Stage2 |
7.557000E-01 |
| Normal-vs-Stage3 |
3.632000E-02 |
| Normal-vs-Stage4 |
3.791800E-02 |
| Stage1-vs-Stage2 |
3.888200E-01 |
| Stage1-vs-Stage3 |
2.604200E-01 |
| Stage1-vs-Stage4 |
2.754200E-01 |
| Stage2-vs-Stage3 |
1.171560E-01 |
| Stage2-vs-Stage4 |
1.189600E-01 |
| Stage3-vs-Stage4 |
8.167600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.859800E-02 |
| Normal-vs-AfricanAmerican |
9.347800E-01 |
| Normal-vs-Asian |
1.510040E-01 |
| Caucasian-vs-AfricanAmerican |
1.246630E-01 |
| Caucasian-vs-Asian |
6.792200E-01 |
| AfricanAmerican-vs-Asian |
3.188600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.788100E-02 |
| Normal-vs-Female |
1.670770E-01 |
| Male-vs-Female |
5.533400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.363600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.087900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.075200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.154000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.188400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.711600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.213200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.386800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.951600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.344200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.012400E-02 |
| Classical-VS-Follicular |
4.645600E-02 |
| Classical-VS-Other |
6.235500E-02 |
| Classical-VS-Normal |
4.604600E-01 |
| Tall-VS-Follicular |
4.432400E-01 |
| Tall-VS-Other |
3.166600E-01 |
| Tall-VS-Normal |
1.441730E-02 |
| Follicular-VS-Other |
2.478800E-01 |
| Follicular-VS-Normal |
4.218200E-02 |
| Other-VS-Normal |
3.086400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.661160E-01 |
| Normal-vs-N1 |
1.597660E-03 |
| N0-vs-N1 |
3.537800E-02 |
|
|
